Monday 24 August 2015, Amsterdam
$ The report “Sleep Apnea Devices Market by Product, Diagnostic (PSG, Pulse Oximeter), Therapeutic [CPAP, APAP, BPAP, Masks (Full Face Mask), Oral Appliances (Mandibular Advancement Device)], End User (Home Care Settings, Hospitals) - Analysis & Global Forecasts to 2020”, analyzes and studies the major market drivers, restraints/challenges, and opportunities.
This report studies the global sleep apnea devices market for the forecast period of 2015 to 2020. This market is expected to reach $5.3 Billion by 2020 from $3.7 Billion in 2015 at a CAGR of 7.2% during the forecast period.
The global market is segmented on the basis of type , end user, and region.
Based on type, the market is categorized into diagnostic and therapeutic devices. In 2015, the therapeutic devices segment is estimated to account for the major share of this market and grow at the highest rate in the forecast period.
Based on end user, the market is segmented into home care and sleep laboratories and hospitals. In 2015, the home care segment is estimated to account for the major share of this market.
On the basis of regions, the market is divided into North America, Europe, Asia- Pacific, and the Rest of the World (RoW). The RoW comprises Latin America, Central America, and Africa. In 2015, North America is estimated to account for the largest share of this market, followed by Europe and Asia- Pacific. However, the European market is slated to grow at the highest CAGR during the forecast period. This region will also be a revenue pocket for market players.
A strong focus on innovation is being observed in this market, by both major players such as ResMed, Inc. (U.S.) and new entrants such as Airing LLC (U.S.). The rich pipeline of innovative products in this market opens an array of opportunities for the market. Players are particularly focused on making devices compact and efficient . Furthermore, start-up companies in this market are also attracting venture capital funding, which is a sign of the opportunities in this market.
Some major players in the global sleep apnea devices market include ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), Fisher & Paykel Healthcare Ltd. (New Zealand), Compumedics Ltd. (Australia), SomnoMed (Australia), and Whole You, Inc. (U.S.).
ASDReports.com Media contact: S. Koopman -
Marketing and Communications
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : email@example.com
back to News